Sanofi eyes other deals after bagging Zentiva

PARIS (Reuters) – Sanofi-Aventis finally clinched its $2 billion takeover of Czech drugmaker Zentiva on Wednesday, boosting its presence in generic medicines and setting the stage for further acquisitions.

Leave a Reply